Events & Earnings Calls
Upcoming Engagements
Entourage’s Third Quarter Financial Results Conference Call to be held on November 29, 2024 at 10:00am Eastern Time
Entourage Health will release its third quarter financials after-market on Thursday, November 28, 2024 followed by a conference call with management on Friday, November 29, 2024 at 10 a.m. Eastern Time to review the results for the period and provide an operational update and recap of achievements.
CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj will host the conference call. Following the opening remarks, management will be available to answer questions.
Date:
Tuesday, November 29, 2024
Time:
10 a.m. Eastern Time
Toll Free Number:
Canada/USA: 1-844-763-8274
International Toll: 1-412-717-9224
Participants, please dial in and ask to join the Entourage call.
Replays
Replay: Entourage’s Second Quarter, 2024 Financial Results Conference Call Held On August 27, 2024
Entourage Health released its Second Quarter, 2024 financial results and held a conference call with analysts on August 27, 2024. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Watch the Q2 Financial Results Conference Call
Replay: Entourage’s First Quarter, 2023 Financial Results Conference Call Held On May 28, 2024
Entourage Health released its First Quarter, 2024 financial results and held a conference call with analysts on May 28, 2024. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s Third Quarter, 2023 Financial Results Conference Call Held On November 28, 2023
Entourage Health released its Third Quarter, 2023 financial results and held a conference call with management on November 28, 2023. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s Second Quarter, 2023 Financial Results Conference Call Held On August 30, 2023
Entourage Health released its Second Quarter, 2023 financial results and held a conference call with analysts on August 30, 2023. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s First Quarter, 2023 Financial Results Conference Call Held On May 30, 2023
Entourage Health released its First Quarter, 2023 financial results and held a conference call with analysts on May 30, 2023. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s Third Quarter, 2022 Financial Results Conference Call Held On November 15, 2022
Entourage Health released its Third Quarter, 2022 financial results and held a conference call with management on November 15, 2022. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s Second Quarter, 2022 Financial Results Conference Call Held On August 30, 2022
Entourage Health released its Second Quarter, 2022 financial results and held a conference call with analysts on August 30, 2022. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Annual General Meeting (“AGM”) of Shareholders
The Company’s Annual General and Special Meeting of Shareholders (“the Meeting”) was held virtually from Toronto, Ontario June 10, 2022 at 11:00 a.m. Eastern Time. The Meeting was hosted by George Scorsis, CEO and Executive Chairman and included a financial update from CFO, Vaani Maharaj.
Replay: Entourage’s First Quarter, 2022 Financial Results Conference Call Held On May 31, 2022
Entourage Health released its First Quarter, 2022 financial results and held a conference call with analysts on May 31, 2022. The conference call was hosted by CEO and Executive Chairman, George Scorsis and CFO, Vaani Maharaj.
Replay: Entourage’s Third Quarter, 2021 Financial Results Conference Call Held On November 16, 2021
Entourage Health released its Third Quarter, 2021 financial results and held a conference call with analysts on November 16, 2021. The conference call was hosted by Interim CEO and Executive Chairman, George Scorsis and CFO, Beth Carreon.
Replay: Entourage’s Second Quarter, 2021 Financial Results Conference Call Held On August 10, 2021
Entourage Health released its Second Quarter, 2021 financial results and held a conference call with analysts on August 10, 2021. The conference call was hosted by Interim CEO and Executive Chairman, George Scorsis and CFO, Beth Carreon.
Replay: Annual General Meeting (“AGM”) of Shareholders
The Company’s Annual General and Special Meeting of Shareholders (“the Meeting”) was held virtually from Toronto, Ontario June 30, 2021 at 11:00 a.m. Eastern Time. The Meeting was hosted by George Scorsis, CEO, and members of the management team and included the Company’s annual outlook and operational update.
Information on the matters considered at the meeting were circulated prior to AGM and are available under WeedMD’s issue profile at www.sedar.com
Replay: WeedMD Fiscal Year, 2020 Financial Results Conference Call Held On May 31, 2021
WeedMD released its Fiscal Year, 2020 financial results and reported Q1, 2021 preliminary gross revenue of $12M during its conference call with analysts on May 31st, 2021. The call was hosted by George Scorsis, CEO and Executive Chair and newly appointed CFO Beth Carreon. Management provided its operational outlook for 2021 and answered analyst questions following opening remarks.
Replay: WeedMD CEO & CFO Presented At Canaccord Genuity’s 5th Annual Global Cannabis Virtual Conference Held On May 11, 2021
George Scorsis, Chief Executive Officer and newly appointed Chief Financial Officer Beth Carreon presented at Canaccord Genuity’s 5th Annual Global Cannabis Virtual Conference on Tuesday, May 11, 2021.
Replay: WeedMD CEO George Scorsis Appeared As A Panelist On The Global Cannabis Industry In 2021 Virtual Summit, Held On April 20, 2021
Replay: WeedMD Third Quarter, 2020 Financial Results Conference Call Held On December 1, 2020
WeedMD released its Third Quarter, 2020 financial results and held a conference call with analysts on December 1st, 2020. The call was hosted by Angelo Tsebelis, CEO of WeedMD and CFO Lincoln Greenidge. Management provided its operational recap for the period and answered analyst questions following opening remarks.
Replay: WeedMD Second Quarter, 2020 Financial Results Conference Call Held On October 1, 2020
WeedMD released its Second Quarter, 2020 financial results and held a conference call with analysts on October 1st, 2020. The call was hosted by Angelo Tsebelis, CEO of WeedMD and CFO Lincoln Greenidge. Management provided its operational outlook for 2020 and answered analyst questions following opening remarks.
Replay: WeedMD Hosts Annual General Meeting (AGM) Of Shareholders
WeedMD’s Annual General and Special Meeting of Shareholders (“the Meeting”) was held virtually in Toronto, Ontario on Friday, July 24, 2020. The meeting was hosted by Executive Chair, George Scorsis and CEO Angelo Tsebelis who was on hand to provide an overview of WeedMD’s business as well as operational update.
Replay: WeedMD First Quarter, 2020 Financial Results Conference Call Held On July 15, 2020
WeedMD released its First Quarter, 2020 financial results and reported net revenue of $12.2M during its conference call with analysts on July 15, 2020. The call was hosted by Angelo Tsebelis, CEO of WeedMD and CFO Lincoln Greenidge. Management provided its operational outlook for 2020 and answered analyst questions following opening remarks.
Replay: WeedMD Fiscal Year, 2019 Financial Results Conference Call Held On June 11, 2020
WeedMD released its Fiscal Year, 2019 financial results and reported Q1, 2020 preliminary net revenue of $12.1M during its conference call with analysts on June 11, 2020. The call was hosted by Angelo Tsebelis, CEO of WeedMD and CFO Lincoln Greenidge. Management provided its operational outlook for 2020 and answered analyst questions following opening remarks.